These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36075146)

  • 1. Identification of L. infantum trypanothione synthetase inhibitors with leishmanicidal activity from a (non-biased) in-house chemical library.
    Alcón-Calderón M; de Lucio H; García-Soriano JC; Revuelto A; de Castro S; López-Gutiérrez C; San-Félix A; Quesada E; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 243():114675. PubMed ID: 36075146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening.
    Benítez D; Franco J; Sardi F; Leyva A; Durán R; Choi G; Yang G; Kim T; Kim N; Heo J; Kim K; Lee H; Choi I; Radu C; Shum D; No JH; Comini MA
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):912-929. PubMed ID: 35306933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.
    Benítez D; Medeiros A; Fiestas L; Panozzo-Zenere EA; Maiwald F; Prousis KC; Roussaki M; Calogeropoulou T; Detsi A; Jaeger T; Šarlauskas J; Peterlin Mašič L; Kunick C; Labadie GR; Flohé L; Comini MA
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004617. PubMed ID: 27070550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen.
    Saudagar P; Saha P; Saikia AK; Dubey VK
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):569-77. PubMed ID: 24002022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and chemical analyses reveal that trypanothione synthetase but not glutathionylspermidine synthetase is essential for Leishmania infantum.
    Sousa AF; Gomes-Alves AG; Benítez D; Comini MA; Flohé L; Jaeger T; Passos J; Stuhlmann F; Tomás AM; Castro H
    Free Radic Biol Med; 2014 Aug; 73():229-38. PubMed ID: 24853758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.
    de Lucio H; García-Marín J; Sánchez-Alonso P; García-Soriano JC; Toro MÁ; Vaquero JJ; Gago F; Alajarín R; Jiménez-Ruiz A
    Eur J Med Chem; 2022 Jan; 227():113915. PubMed ID: 34695777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
    Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
    Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
    Leroux AE; Krauth-Siegel RL
    Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity.
    de Lucio H; Revuelto A; Carriles AA; de Castro S; García-González S; García-Soriano JC; Alcón-Calderón M; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 244():114878. PubMed ID: 36332553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.
    Mesías AC; Sasoni N; Arias DG; Pérez Brandán C; Orban OCF; Kunick C; Robello C; Comini MA; Garg NJ; Zago MP
    Free Radic Biol Med; 2019 Jan; 130():23-34. PubMed ID: 30359758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Amides Containing Selenium as Potent Leishmanicidal Agents Targeting Trypanothione Reductase.
    Etxebeste-Mitxeltorena M; Plano D; Espuelas S; Moreno E; Aydillo C; Jiménez-Ruiz A; Soriano JCG; Sanmartín C
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Antileishmanial Chemotypes By High-Throughput Virtual and In Vitro Screening.
    Khan H; Hakami MA; Alamri MA; Alotaibi BS; Ullah N; Khan R; Khalid A; Abdalla AN; Wadood A
    Acta Parasitol; 2024 Sep; 69(3):1439-1457. PubMed ID: 39150581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
    Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
    Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.
    de Lucio H; Toro MA; Camarasa MJ; Velázquez S; Gago F; Jiménez-Ruiz A
    Br J Pharmacol; 2020 Nov; 177(22):5163-5176. PubMed ID: 32888319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening.
    Phan TN; Park KP; Benítez D; Comini MA; Shum D; No JH
    Biochem Biophys Res Commun; 2022 Dec; 637():308-313. PubMed ID: 36413853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
    Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
    Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanothione biosynthesis in Leishmania major.
    Oza SL; Shaw MP; Wyllie S; Fairlamb AH
    Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanothione synthesis in crithidia revisited.
    Comini M; Menge U; Wissing J; Flohé L
    J Biol Chem; 2005 Feb; 280(8):6850-60. PubMed ID: 15537651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
    Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.